A serum metabolic biomarker panel for early rheumatoid arthritis

OBJECTIVE: There is an urgent need for novel biomarkers to improve the early diagnosis of rheumatoid arthritis (ERA). Current serum biomarkers used in the management of ERA, including rheumatoid factor and anti-cyclic citrullinated peptide (ACPA), show limited specificity and sensitivity. Here, we u...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Muguruza, Samantha, Altuna-Coy, Antonio, Arreaza-Gil, Verónica, Mendieta-Homs, Marina, Castro-Oreiro, Sonia, Poveda-Elices, Maria José, del Castillo-Piñol, Nuria, Fontova-Garrofé, Ramon, Chacón, Matilde R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502709/
https://www.ncbi.nlm.nih.gov/pubmed/37720214
http://dx.doi.org/10.3389/fimmu.2023.1253913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502709/
https://www.ncbi.nlm.nih.gov/pubmed/37720214
http://dx.doi.org/10.3389/fimmu.2023.1253913

Ejemplares similares